Literature DB >> 17544697

Surgical approaches and complications in the removal of vestibular schwannomas.

Marc Bennett1, David S Haynes.   

Abstract

Vestibular schwannomas are benign tumors that usually originate from the balance portion of cranial nerve VIII. The treatment options currently available for vestibular schwannomas include observation with serial imaging, stereotactic radiation, and microsurgical removal. Although the ultimate goal in treatment of vestibular schwannomas is preservation of life, the best option for each patient depends on symptoms, tumor size, tumor location, and the patient's general health and age. Surgical exposure of the cerebellopontine angle for removal of vestibular schwannomas can be performed safely via a translabyrinthine, retrosigmoid, and middle fossa approach. Each approach has its advantages and disadvantages. The goal of surgery is complete eradication of tumor with preservation of hearing and facial nerve function when possible.

Entities:  

Mesh:

Year:  2007        PMID: 17544697     DOI: 10.1016/j.otc.2007.03.007

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  15 in total

1.  From external to internal auditory canal: surgical anatomy by an exclusive endoscopic approach.

Authors:  Daniele Marchioni; Matteo Alicandri-Ciufelli; Francesco Mattioli; Joao Flavio Nogeira; Muuaz Tarabichi; Domenico Villari; Livio Presutti
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-03       Impact factor: 2.503

Review 2.  [Value of different strategies in the treatment of vestibular schwannoma: therapeutic aspects and literature analysis].

Authors:  W Maier; T D Grauvogel; R Laszig; G J Ridder
Journal:  HNO       Date:  2011-05       Impact factor: 1.284

3.  [Acoustic neuroma (vestibular schwannoma) therapy from an oto-rhino-laryngological perspective].

Authors:  K Schwager
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

4.  Vestibular schwannoma removal through expanded transcanal transpromontorial approach: a multicentric experience.

Authors:  Giulia Molinari; Federico Calvaruso; Livio Presutti; Daniele Marchioni; Matteo Alicandri-Ciufelli; Filippo Friso; Ignacio Javier Fernandez; Pietro Francoli; Flavia Di Maro
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-08       Impact factor: 3.236

5.  Expanded transcanal transpromontorial approach to the internal auditory canal and cerebellopontine angle: a cadaveric study.

Authors:  L Presutti; M Bonali; D Marchioni; G Pavesi; A Feletti; L Anschuetz; M Alicandri-Ciufelli
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-06       Impact factor: 2.124

6.  Endoscopic Transcanal Retrocochlear Approach to the Internal Auditory Canal with Cochlear Preservation: Pilot Cadaveric Study.

Authors:  Judith Kempfle; Elliott D Kozin; Aaron K Remenschneider; Andreas Eckhard; Albert Edge; Daniel J Lee
Journal:  Otolaryngol Head Neck Surg       Date:  2016-03-01       Impact factor: 3.497

7.  The keyhole retrosigmoid approach to the cerebello-pontine angle: indications, technical modifications, and results.

Authors:  Badr Eldin Mostafa; Mohammed El Sharnoubi; Ahmed Maher Youssef
Journal:  Skull Base       Date:  2008-11

8.  Cochleo-facial corridor to the vestibule and fundus of the internal auditory canal through oval window: a minimal invasive and cochlea sparing approach.

Authors:  Derya Ümit Talas; Orhan Beger; Yusuf Vayisoğlu; Vural Hamzaoğlu; Hakan Özalp; Salim Çakır; Ahmet Dağtekin; Celal Bağdatoğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-17       Impact factor: 2.503

9.  Postoperative headache after surgical treatment of cerebellopontine angle tumors: a systematic review.

Authors:  Louis Pogoda; Jelle S Nijdam; Diederik P J Smeeing; Eduard H J Voormolen; Fuat Ziylan; Hans G X M Thomeer
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-01       Impact factor: 2.503

10.  What really decides the facial function of vestibular schwannoma surgery?

Authors:  Jin Kim; In Seok Moon; Jun Hui Jeong; Hyung Rok Lee; Won Sang Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-12-15       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.